Pavmed Inc. - Net Worth and Insider Trading

Pavmed Inc. Net Worth

The estimated net worth of Pavmed Inc. is at least $30 Million dollars as of 2024-11-13. Pavmed Inc. is the 10% Owner of Lucid Diagnostics Inc and owns about 27,927,190 shares of Lucid Diagnostics Inc (LUCD) stock worth over $30 Million. Details can be seen in Pavmed Inc.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Pavmed Inc. has not made any transactions after 2021-10-18 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Pavmed Inc.

To

Pavmed Inc. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Pavmed Inc. owns 1 companies in total, including Lucid Diagnostics Inc (LUCD) .

Click here to see the complete history of Pavmed Inc.’s form 4 insider trades.

Insider Ownership Summary of Pavmed Inc.

Ticker Comapny Transaction Date Type of Owner
LUCD Lucid Diagnostics Inc 2021-10-18 10 percent owner

Pavmed Inc. Latest Holdings Summary

Pavmed Inc. currently owns a total of 1 stock. Pavmed Inc. owns 27,927,190 shares of Lucid Diagnostics Inc (LUCD) as of October 18, 2021, with a value of $30 Million.

Latest Holdings of Pavmed Inc.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LUCD Lucid Diagnostics Inc 2021-10-18 27,927,190 1.06 29,602,821

Holding Weightings of Pavmed Inc.


Pavmed Inc. Form 4 Trading Tracker

According to the SEC Form 4 filings, Pavmed Inc. has made a total of 1 transactions in Lucid Diagnostics Inc (LUCD) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lucid Diagnostics Inc is the acquisition of 571,428 shares on October 18, 2021, which cost Pavmed Inc. around $8 Million.

Insider Trading History of Pavmed Inc.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Pavmed Inc. Trading Performance

GuruFocus tracks the stock performance after each of Pavmed Inc.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Pavmed Inc. is -56.68%. GuruFocus also compares Pavmed Inc.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Pavmed Inc. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Pavmed Inc.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Pavmed Inc.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.59 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 2.73 LIMIT LIMIT LIMIT LIMIT LIMIT

Pavmed Inc. Ownership Network

Ownership Network List of Pavmed Inc.

No Data

Ownership Network Relation of Pavmed Inc.

Insider Network Chart

Pavmed Inc. Owned Company Details

What does Lucid Diagnostics Inc do?

Who are the key executives at Lucid Diagnostics Inc?

Pavmed Inc. is the 10 percent owner of Lucid Diagnostics Inc. Other key executives at Lucid Diagnostics Inc include General Counsel Michael Adam Gordon , Chief Operating Officer Shaun O'neil , and director & Chief Executive Officer Lishan Aklog .

Lucid Diagnostics Inc (LUCD) Insider Trades Summary

Over the past 18 months, Pavmed Inc. made no insider transaction in Lucid Diagnostics Inc (LUCD). Other recent insider transactions involving Lucid Diagnostics Inc (LUCD) include a net sale of 37,781 shares made by Stanley Lapidus ,

In summary, during the past 3 months, insiders sold 0 shares of Lucid Diagnostics Inc (LUCD) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,781 shares of Lucid Diagnostics Inc (LUCD) were sold and 0 shares were bought by its insiders, resulting in a net sale of 37,781 shares.

Lucid Diagnostics Inc (LUCD)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lucid Diagnostics Inc Insider Transactions

No Available Data

Pavmed Inc. Mailing Address

Above is the net worth, insider trading, and ownership report for Pavmed Inc.. You might contact Pavmed Inc. via mailing address: 360 Madison Avenue, 25th Floor, New York Ny 10017.